- Report
- May 2024
- 133 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- April 2024
- 146 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- April 2024
- 137 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- January 2025
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2024
- 244 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- October 2024
- 237 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- October 2024
- 149 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- January 2025
- 182 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2019
- 144 Pages
Global
From €1312EUR$1,375USD£1,099GBP
€2625EUR$2,750USD£2,199GBP
- Report
- December 2023
- 180 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- November 2023
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- February 2023
- 220 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- August 2022
- 120 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2022
- 117 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2022
- 115 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3102EUR$3,250USD£2,599GBP
- Report
- September 2023
- 200 Pages
Global
From €3435EUR$3,599USD£2,878GBP

The Vasodilator market is a segment of the Medical Devices industry that focuses on the development and sale of products used to widen blood vessels. These products are used to treat a variety of conditions, including hypertension, coronary artery disease, and peripheral vascular disease. Vasodilators are typically administered through injection, infusion, or inhalation, and can be used to reduce blood pressure, improve blood flow, and reduce the risk of stroke and heart attack.
The Vasodilator market is highly competitive, with a number of large and small companies offering a variety of products. Major players in the market include Pfizer, Merck, Novartis, and Sanofi, while smaller companies such as Bausch Health, Mylan, and Teva Pharmaceuticals also offer products. Additionally, many generic drug manufacturers produce generic versions of popular vasodilators. Show Less Read more